GlassScriptPhysician profile
Krista Bowers
NPI 1467464453
$5,236.00
in general payments reported to CMS, 2019-2025
43 companies · $871 in 2025
The $871 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $309 · 2021: $505 · 2022: $810 · 2023: $840 · 2024: $1,045 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,755.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $832.83 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $611.53 | 2019-2025 | Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $583.50 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $476.45 | 2020-2025 | Mounjaro, Zepbound, Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.77 | 2019-2025 | Jardiance |
| Amgen INC. | $335.70 | 2019-2025 | Repatha, Otezla, Otezla |
| Amneal Pharmaceuticals LLC | $305.94 | 2019-2025 | Unithroid |
| Pfizer INC. | $257.01 | 2019-2025 | |
| Astellas Pharma US INC | $242.43 | 2020-2024 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $94.33 | 2019-2024 | Spravato |
| Glaxosmithkline, LLC. | $90.08 | 2019-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $89.05 | 2023-2025 | Cologuard Collection Kit |
| Ucb, INC. | $86.40 | 2025 | Bimzelx |
| Amarin Pharma, INC. | $85.77 | 2019-2021 | |
| Alfasigma USA, INC. | $57.03 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.